Orlando Quintero Cardona, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cardona’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A162401 · Current
Licensed to practise in California · since 2019 · expires 2027-05-31 · Free University of Cali Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$117,331
Medicare paid this office $117,331 for 273 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $33,099 | $105 |
| Critical care, first 30-74 minutes | 40 | $21,190 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 131 | $21,111 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 113 | $10,751 | $70 |
| Return visit (30+ min) | 44 | $9,309 | $118 |
See all 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $33,099 | $105 |
| Critical care, first 30-74 minutes | 40 | $21,190 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 131 | $21,111 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 113 | $10,751 | $70 |
| Return visit (30+ min) | 44 | $9,309 | $118 |
| New patient visit (60+ min) | 45 | $8,875 | $197 |
| Long return visit (40+ min) | 51 | $8,710 | $167 |
| Short return visit (20+ min) | 25 | $3,058 | $80 |
| Short return visit | 12 | $888 | $52 |
Who their Medicare patients are
273 Original Medicare patients in 2024. Average age 76 · Under 65 11% · 85 and older 23% · Women 50% · Also on Medicaid 34% · Health risk score 2.86. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 59% · Coronary heart disease 48% · Diabetes 47% · Heart failure 41% · Atrial fibrillation 37% · Depression 33% · Dementia 27% · COPD 25% · Cancer 19% · Stroke 15%.
The office billed $607,425, Medicare allowed $149,222 and paid $117,331; for 961 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 273 | 961 | 76 | 2.86 | $607,425 | $117,331 |
| 2023 | 244 | 993 | 76 | 3.00 | $570,250 | $107,302 |
| 2022 | 227 | 1,008 | 76 | 2.72 | $615,651 | $110,133 |
| 2021 | 143 | 626 | 75 | 2.56 | $318,987 | $64,679 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $25,629 | $105 |
| Critical care, first 30-74 minutes | 46 | $21,847 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 128 | $21,754 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $13,486 | $70 |
| Long return visit (40+ min) | 36 | $5,928 | $160 |
| Return visit (30+ min) | 34 | $5,537 | $115 |
| New patient visit (60+ min) | 23 | $4,675 | $203 |
| Short return visit (20+ min) | 24 | $3,327 | $81 |
| Telehealth originating site facility fee | 52 | $2,533 | $22 |
| Short return visit | 11 | $1,121 | $53 |
2022: 9 services
| Critical care, first 30-74 minutes | 51 | $29,348 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $25,834 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $19,330 | $176 |
| Return visit (30+ min) | 44 | $12,548 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $7,194 | $63 |
| New patient visit (60+ min) | 25 | $4,989 | $200 |
| Long return visit (40+ min) | 29 | $4,844 | $167 |
| Telehealth originating site facility fee | 59 | $3,104 | $21 |
| Short return visit (20+ min) | 14 | $1,444 | $80 |
2021: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $25,486 | $92 |
| Critical care, first 30-74 minutes | 36 | $11,593 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,383 | $180 |
| Return visit (30+ min) | 27 | $6,252 | $120 |
| Long return visit (40+ min) | 25 | $4,299 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,826 | $64 |
| Telehealth originating site facility fee | 45 | $1,930 | $22 |
| Short return visit (20+ min) | 14 | $1,435 | $84 |
Medicaid work
$2,659 in 2024
Medicaid paid $2,659 for 56 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 56 | $2,659 |
| 2024 | 56 | 1 | 13 | $2,659 |
| 2023 | 45 | 2 | 13 | $735 |
| 2022 | 23 | 1 | 12 | $360 |
| 2021 | 43 | 1 | 14 | $1,143 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 27 | $430 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 18 | $305 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $360 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 43 | $1,143 |
Drugs they prescribed that Part D paid
$16,435
Pharmacies billed $16,435 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 259) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
240 generic and 19 brand-name prescriptions · $16,435 in drug cost · 198 antibiotic prescriptions to 64 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fosfomycin Tromethamine | 11 | $2,496 | $227 |
| Methenamine Hippurate | 25 | $1,297 | $52 |
| Nitrofurantoin Mono-Macro | 38 | $1,150 | $30 |
| Doxycycline Hyclate | 30 | $1,143 | $38 |
| Nitrofurantoin | 18 | $948 | $53 |
See all 8 drugs
| Fosfomycin Tromethamine | 11 | $2,496 | $227 |
| Methenamine Hippurate | 25 | $1,297 | $52 |
| Nitrofurantoin Mono-Macro | 38 | $1,150 | $30 |
| Doxycycline Hyclate | 30 | $1,143 | $38 |
| Nitrofurantoin | 18 | $948 | $53 |
| Vancomycin | 18 | $835 | $46 |
| Ciprofloxacin | 21 | $82 | $4 |
| Cephalexin | 11 | $54 | $5 |
Year by year
| 2024 | 259 | 79 | 0% (0) | 7% | $16,435 |
| 2023 | 288 | 55 | 0% (0) | 9% | $38,917 |
| 2022 | 230 | 47 | 0% (0) | 14% | $38,728 |
| 2021 | 126 | 36 | 0% (0) | 19% | $20,582 |
| 2019 | 271 | 13 | 0% (0) | None | $206,833 |
| 2018 | 301 | 18 | 0% (0) | None | $243,805 |
| 2017 | 426 | 50 | 0% (0) | 20% | $27,125 |
| 2016 | 582 | 72 | None | 21% | $47,779 |
| 2015 | 96 | 18 | 0% (0) | None | $4,176 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Entecavir | 11 | $5,634 | $512 |
| Fosfomycin Tromethamine | 20 | $4,172 | $209 |
| Nitrofurantoin Mono-Macro | 13 | $1,019 | $78 |
| Vancomycin | 20 | $1,012 | $51 |
| Methenamine Hippurate | 18 | $909 | $50 |
| Cefdinir | 31 | $767 | $25 |
| Cephalexin | 21 | $481 | $23 |
| Nitrofurantoin | 16 | $479 | $30 |
| Ciprofloxacin | 20 | $125 | $6 |
| Sulfamethoxazole-Trimethoprim | 12 | $116 | $10 |
| Levofloxacin | 20 | $114 | $6 |
| Isoniazid | 12 | $76 | $6 |
2022: 7 drugs
| Fosfomycin Tromethamine | 27 | $5,428 | $201 |
| Cefdinir | 29 | $1,543 | $53 |
| Nitrofurantoin Mono-Macro | 25 | $1,345 | $54 |
| Rifampin | 15 | $1,128 | $75 |
| Cephalexin | 26 | $552 | $21 |
| Ciprofloxacin | 36 | $293 | $8 |
| Amoxicillin | 11 | $155 | $14 |
2021: 4 drugs
| Fosfomycin Tromethamine | 12 | $1,854 | $155 |
| Cephalexin | 17 | $451 | $27 |
| Nitrofurantoin Mono-Macro | 20 | $407 | $20 |
| Ciprofloxacin | 14 | $276 | $20 |
2019: 6 drugs
| Genvoya | 16 | $50,325 | $3,145 |
| Odefsey | 14 | $49,949 | $3,568 |
| Nevirapine | 12 | $564 | $47 |
| Triamterene-Hydrochlorothiazid | 13 | $96 | $7 |
| Amlodipine Besylate | 24 | $59 | $2 |
| Atorvastatin | 13 | $47 | $4 |
2018: 9 drugs
| Odefsey | 12 | $52,615 | $4,385 |
| Genvoya | 14 | $43,126 | $3,080 |
| Tivicay | 19 | $32,514 | $1,711 |
| Descovy | 18 | $31,896 | $1,772 |
| Edurant | 12 | $12,339 | $1,028 |
| Rosuvastatin | 11 | $969 | $88 |
| Triamterene-Hydrochlorothiazid | 13 | $89 | $7 |
| Amlodipine Besylate | 20 | $47 | $2 |
| Metformin | 14 | $34 | $2 |
2017: 11 drugs
| Lantus Solostar | 13 | $4,723 | $363 |
| Januvia | 11 | $4,219 | $384 |
| Ventolin Hfa | 13 | $674 | $52 |
| Atorvastatin | 18 | $217 | $12 |
| Metformin | 49 | $156 | $3 |
| Simvastatin | 30 | $128 | $4 |
| Lisinopril | 29 | $115 | $4 |
| Metoprolol | 30 | $107 | $4 |
| Glimepiride | 13 | $65 | $5 |
| Losartan | 23 | $61 | $3 |
| Sertraline | 12 | $29 | $2 |
2016: 16 drugs
| Januvia | 25 | $9,020 | $361 |
| Lantus Solostar | 16 | $5,734 | $358 |
| Crestor | 11 | $2,695 | $245 |
| Levothyroxine | 19 | $308 | $16 |
| Chlorthalidone | 11 | $304 | $28 |
| Nifedipine Er | 14 | $272 | $19 |
| Metformin | 46 | $179 | $4 |
| Losartan | 27 | $115 | $4 |
| Simvastatin | 44 | $107 | $2 |
| Lisinopril | 25 | $106 | $4 |
| Glipizide | 14 | $41 | $3 |
| Alendronate | 11 | $32 | $3 |
| Metoprolol | 13 | $29 | $2 |
| Hydrochlorothiazide | 13 | $25 | $2 |
| Atenolol | 11 | $23 | $2 |
| Amlodipine Besylate | 13 | $20 | $2 |
2015: 2 drugs
| Simvastatin | 19 | $46 | $2 |
| Amlodipine Besylate | 11 | $36 | $3 |
Professional record
- NPI
- 1043624703
- Licence
- CA A162401California A162401: Current · expires 2027-05-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-06-19
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.